Jump to content

Patent application for antiviral drug Favipiravir rejected by Thai officials


Recommended Posts

The patent application for the Japanese antiviral drug Favipiravir used to treat Covid-19 has been rejected in Thailand. With thousands of Covid-19 patients in hospitals and field hospitals, the Thai government made emergency orders for the drug, and sought permission for the right to produce the medicine locally. An application had been filed under the compulsory license system where the government allows a company to produce a patented product in an emergency and for non-commercial use. The application was rejected by Thailand’s Intellectual Property Department and the department’s director general says it failed to meet the requirements for registration, according to […]

The post Patent application for antiviral drug Favipiravir rejected by Thai officials appeared first on Thaiger News.

Read the full story

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
×
×
  • Create New...

Important Information

By posting on Thaiger Talk you agree to the Terms of Use